section name header
Index
Anticoagulants for Preventing Recurrence after Acute Ischaemic Stroke
Anticoagulants Versus Nsaids or Placebo for Venous Thromboembolism
Anticoagulant Therapy in Acute (Duration Less Than 48 Hours) Atrial Fibrillation
Anticoagulant Treatment in Acute Cardioembolic Stroke
Anticoagulation for Atrial Fibrillation
Anticoagulation for Atrial Fibrillation - Flowchart
Anticoagulation for Cerebral Sinus Thrombosis
Anticoagulation for Heart Failure in Sinus Rhythm
Anticoagulation for the Intial Treatment of Venous Thromboembolism in Patients with Cancer
Anticoagulation for the Long Term Treatment of Venous Thromboembolism in Patients with Cancer
Anticoagulation for Thrombosis Prophylaxis in Cancer Patients with Central Venous Catheters
Antiplatelet and Anticoagulation for Patients with Prosthetic Heart Valves
Antiplatelet Therapy for Patients with Non-Valvular Atrial Fibrillation
Antithrombotic Agents for Preventing Thrombosis after Infrainguinal Arterial Bypass Surgery
Antithrombotic Agents in Primary Health Care - Related Resources
Antithrombotic Drugs for Carotid Dissection
Antithrombotic Treatment after Stroke Due to Intracerebral Haemorrhage
ASA for Hypertension
Cardiology
Closure Vs. Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or TIA
Cochrane review
Computer-Assisted Management of Anticoagulant Therapy
Deep Vein Thrombosis - Related Resources
Evidence summary
Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for First Episode of Venous Thromboembolism Vs Fatal Bleeding during Continued Anticoagulation
Female
Fondaparinux for Acute Coronary Syndromes
Haematology
Indications for and Implementation of Anticoagulant Therapy in Atrial Fibrillation - Related Resources
Internal medicine
Interventions for Haemolytic Uraemic Syndrome (Hus) and Thrombotic Thrombocytopenic Purpura (TTP)
Long Versus Short Duration of Anticoagulant Therapy after a First Episode of Venous Thromboembolism
Low-Intensity Warfarin for Long-Term Prevention of Venous Thromboembolism
Lung Cancer - Related Resources
Neurology
Noac Versus Warfarin Postpci in Atrial Fibrillation
Non-Invasive Diagnosis of Deep Venous Thrombosis
Oncology
Optimal Loading Dose of Warfarin for the Initiation of Oral Anticoagulation
Oral Anticoagulants Vs Antiplatelet Therapy for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Stroke or TIA
Oral Anticoagulation for Prolonging Survival in Patients with Cancer
Oral Contraceptives in Patients Who have Experienced One Venous Thrombosis
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Deep Vein Thrombosis
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism
Parenteral Anticoagulation in Ambulatory Patients with Cancer
Pharmacology
Prevention of Venous Thromboembolism - Related Resources
Radiotherapy
Selecting Anticoagulant Therapy in Atrial Fibrillation
Self-Monitoring and Self-Management of Oral Anticoagulation
Systematic review
Thrombolysis for Acute Deep Vein Thrombosis
Treatment of Distal Deep Vein Thrombosis
Vena Caval Filters for the Prevention of Pulmonary Embolism
Vitamin K Antagonists Versus Antiplatelet Therapy after TIA or Minor Ischaemic Stroke of Presumed Arterial Origin
Vitamin K for Improved Anticoagulation Control in Patients Receiving Warfarin
Warfarin for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Cerebral Ischaemia
Warfarin or Antiplatelet Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Warfarin Therapy - Related Resources